Urinary neurotrophic factor levels in prostate cancer patients with brachytherapy-realted overactive bladder sympton

Urinary neurotrophic factor levels in prostate cancer patients with brachytherapy-realted overactive bladder sympton - Urinary biomarker study in brachytherapy-realted OAB

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000011557

Enrollment

Registered

2013-09-01

Start date

2013-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

overactive bladder

Interventions

None listed

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Prostate cancer patients recieving brachytherapy

Exclusion criteria

Exclusion criteria: Residual urine volume >100ml Concomitant urinary tract infection

Design outcomes

Primary

Measure	Time frame
To identify the urinary biomarker which correlates with voiding sympton scores.	—

Countries

Japan

Contacts

Public ContactToshiaki Shinojima

Keio University School of Medicine Department of Urology

t-shinoj@cd5.so-net.ne.jp03-3353-1211

Outcome results